Document ID: chunk:federal_register_of_legislation:F2025L00064:schedule:1
Version: federal_register_of_legislation:F2025L00064
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2476–3105

Schedule 1—Amendments

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)

     1.            Schedule 4, entries for Carmellose
    omit:
Carmellose  Eye drops containing carmellose sodium 5 mg per mL, 15 mL
Carmellose  Eye drops containing carmellose sodium 10 mg per mL, 15 mL

     1.            Schedule 4, omit entry for Carmellose with glycerin
     2.            Schedule 4, after entry for Estradiol in the form Transdermal patches 390 micrograms, 8
    insert:
Estradiol  Transdermal patches 390 micrograms, 24 (S19A)